SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001144204-17-036873
Filing Date
2017-07-14
Accepted
2017-07-14 17:25:24
Documents
8
Effectiveness Date
2017-07-14

Document Format Files

Seq Description Document Type Size
1 DEFM14A v470292_defm14a.htm DEFM14A 2125001
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_amri-2line.jpg GRAPHIC 22185
4 GRAPHIC sig_lori-henderson.jpg GRAPHIC 12111
5 GRAPHIC sig_william-marth.jpg GRAPHIC 18373
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v470292_proxycard-1.jpg GRAPHIC 578875
8 GRAPHIC v470292_proxycard-2.jpg GRAPHIC 710035
  Complete submission text file 0001144204-17-036873.txt   3974194
Mailing Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154
Business Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154 5184640279
ALBANY MOLECULAR RESEARCH INC (Filer) CIK: 0001065087 (see all company filings)

IRS No.: 141742717 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35622 | Film No.: 17966154
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9